Press enter to activate the dialog and use the tab key to navigate through the options.

Neurocrine Biosciences Company Logo
  1. Top Workplaces
  2. Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences is a San Diego based biopharmaceutical company dedicated to relieving patient suffering and enhancing the lives of patients with neurological and endocrine related diseases and disorders.

Neurocrine discovered, developed and markets INGREZZA® (valbenazine), the first FDA-approved product indicated for the treatment of adults with tardive dyskinesia, a movement disorder. Discovered and developed through Phase II clinical trials by Neurocrine, ORILISSA™ (elagolix), the first FDA-approved oral medication for the management of endometriosis with associated moderate to severe pain in over a decade, is marketed by AbbVie as part of a collaboration to develop and commercialize elagolix for women's health. Neurocrine's clinical development programs include opicapone for Parkinson's disease patients, elagolix for uterine fibroids with AbbVie, valbenazine for the treatment of Tourette syndrome, and NBI-74788 for the treatment of congenital adrenal hyperplasia.
... Read more

Vision

Delivering on hope... Read more

Mission

To relieve patient suffering and enhance lives... Read more

Values

Passion
We are driven and love what we do. We are committed to our goals and to making a difference.

Headquarters

SAN DIEGO, CA

Employees

491 US Employees

Industry

Biotechnology

Recent Awards

  • 2018

Company Snapshots